Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
The COVID-19 pandemic was immediately marked by strong clinical research activity. The French national competent authority presents the data on request for authorization during the first 2 years of COVID-19 pandemic to inform discussions on future clinical research issues. Applications for authoriza...
Saved in:
Main Authors: | Stéphane Vignot (Author), Alban Dhanani (Author), Isabelle Sainte-Marie (Author), Laure de Ligniville Lajavardi (Author), Gwennaelle Even (Author), Muriel Echemann (Author), Nina Hulin (Author), Claire Ménoret (Author), Patrick Maison (Author), Christelle Ratignier-Carbonneil (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
by: Stéphane Vignot, et al.
Published: (2021) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
by: Patrick Maison, et al.
Published: (2022) -
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
by: Laëtitia Belgodère, et al.
Published: (2023) -
Pharmacist Prescriptive Authority: Lessons from Idaho
by: Alex J. Adams
Published: (2020) -
About the Author
by: Yulia N. Grekova, et al.
Published: (2022)